We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.53B
AUM Growth
+$37.9M
Cap. Flow
-$42.4M
Cap. Flow %
-1.2%
Top 10 Hldgs %
14.48%
Holding
249
New
18
Increased
88
Reduced
94
Closed
13

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$18.6M
2
CTCT
CONSTANT CONTACT, INC COM
CTCT
+$15.1M
3
SPNC
Spectranetics Corp
SPNC
+$13.9M
4
HUBS icon
HubSpot
HUBS
+$12.9M
5
EVH icon
Evolent Health
EVH
+$12.4M

Top Sells

Rank Stock Value
1
MTD icon
Mettler-Toledo International
MTD
+$34.8M
2
AXON
Axon Enterprise
AXON
+$25.2M
3
OMG
OM GROUP INC.
OMG
+$22.2M
4
FDS icon
Factset
FDS
+$16.4M
5
ARUN
ARUBA NETWORKS, INC.
ARUN
+$15.9M

Sector Composition

Rank Sector Weight
1 Technology 33.1%
2 Healthcare 17.56%
3 Industrials 12.5%
4 Consumer Discretionary 10.03%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QMCO icon
226
Quantum Corp
QMCO
$474M
$1.63M 0.05%
+6,058
New +$1.85M
DARE icon
227
Dare Bioscience
DARE
$21M
$1.53M 0.04%
2,769
+1,171
+73% +$804K
AGRX
228
DELISTED
Agile Therapeutics
AGRX
$1.52M 0.04%
89
-2
-2% -$42.7K
SPA
229
DELISTED
Sparton
SPA
$1.22M 0.03%
44,724
-1,110
-2% -$29.7K
AVEO
230
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.19M 0.03%
68,465
– –
WNC icon
231
Wabash National
WNC
$527M
$840K 0.02%
67,000
-767,700
-92% -$10.7M
TRVN
232
DELISTED
Trevena, Inc.
TRVN
$788K 0.02%
+202
New +$854K
FLNA
233
Filana Therapeutics
FLNA
$48.1M
$584K 0.02%
48,249
-1,191
-2% -$16.3K
COSI
234
DELISTED
COSI INC NEW COM STK (DE)
COSI
$567K 0.02%
+282,250
New +$674K
NSPH
235
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$425K 0.01%
131,229
-849
-0.6% -$3.26K
BSTG
236
DELISTED
Biostage, Inc. Common Stock
BSTG
$280K 0.01%
195,915
-130,014
-40% -$318K
HZO icon
237
MarineMax
HZO
$788M
– –
-496,341
Closed -$13.2M
IRWD icon
238
Ironwood Pharmaceuticals
IRWD
$714M
– –
-275,575
Closed -$3.69M
MTD icon
239
Mettler-Toledo International
MTD
$28.6B
– –
-105,750
Closed -$34.8M
SGMO
240
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-95,400
Closed -$1.5M
SRPT icon
241
Sarepta Therapeutics
SRPT
$1.77B
– –
-245,866
Closed -$3.27M
MXPT
242
DELISTED
MaxPoint Interactive, Inc.
MXPT
– –
-81,050
Closed -$3.11M
DMND
243
DELISTED
DIAMOND FOODS, INC.
DMND
– –
-14,127
Closed -$460K
PSEM
244
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
– –
-265,899
Closed -$4.11M
ARUN
245
DELISTED
ARUBA NETWORKS, INC.
ARUN
– –
-650,500
Closed -$15.9M
HPTX
246
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
– –
-49,400
Closed -$2.27M
RVBD
247
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
– –
-160,000
Closed -$3.35M
ENV
248
DELISTED
ENVESTNET, INC.
ENV
– –
-54,382
Closed -$3.05M
KEG
249
DELISTED
KEY ENERGY SERVICES INC
KEG
– –
-1,216,460
Closed -$2.21M
6 7 8 9
10

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Granahan Investment Management held 249 positions worth $3.53B, up 1.1% from $3.49B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Granahan Investment Management's Q2 2015 filing shows 18 new, 88 increased, 94 reduced and 13 closed positions. Its largest new stake was HubSpot: 281,176 shares worth $13.9M. The largest sale was Mettler-Toledo International, an estimated $34.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q2 2015 buy was HubSpot: 281,176 shares worth $13.9M.
  • Granahan Investment Management added most to Ligand Pharmaceuticals in Q2 2015, an estimated $18.6M increase.
  • Granahan Investment Management's biggest Q2 2015 reduction was Axon Enterprise, cutting an estimated $25.2M.
  • Granahan Investment Management fully exited Mettler-Toledo International in Q2 2015, selling an estimated $34.8M.
  • Granahan Investment Management's ten largest holdings make up 14% of its $3.53B portfolio in Q2 2015.
  • Granahan Investment Management opened 18 new positions and closed 13 in Q2 2015.
  • Granahan Investment Management's portfolio value rose 1.1% quarter-over-quarter to $3.53B.

Based on Granahan Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.